Clinical trials: Appetite Suppression
- Condition Appetite Suppression
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Appetite Regulation, Appetite Suppression
Efficacy and Safety of IQP-AK-102 in Reducing Appetite
The primary cause of being overweight is an imbalance in calories consumed and energy expenditure. A surplus in energy intake might result in body fat deposition and thereby body weight gain.
- Conditions
- Appetite Regulation, Appetite Suppression, Energy Intake
- Trial name
- NCT02774486
- Testing
- IQP-AK-102
- Where
- Germany
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- InQpharm Group
Overweight, Obesity
A Controlled Study to Evaluate the Effects of a Supplement on Weight Loss, Blood Sugar, and Appetite Suppression
This is a randomized, controlled, hybrid clinical trial evaluating the effects of the Evolv GLP-1 supplement on weight loss, blood sugar regulation, and appetite suppression over 12 weeks.
- Conditions
- Overweight, Obesity, Blood Sugar Regulation, Appetite Suppression
- Trial name
- NCT07889570
- Testing
- Evolv GLP-1 Group, Control Group
- Where
- United States
- Volunteers
- 98 people, healthy volunteers welcome
- Sponsor
- Evolv